Kihwan Kwon
Overview
Explore the profile of Kihwan Kwon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
658
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim H, Choi Y, Kim K, Byun Y, Kim T, Kim J, et al.
J Extracell Vesicles
. 2024 Sep;
13(9):e12508.
PMID: 39323378
Extracellular vesicles (EVs) have emerged as a potential delivery vehicle for nucleic-acid-based therapeutics, but challenges related to their large-scale production and cargo-loading efficiency have limited their therapeutic potential. To address...
2.
Song S, Woo J, Kim H, Lee J, Lim W, Moon B, et al.
Front Cardiovasc Med
. 2024 Feb;
11:1324203.
PMID: 38385137
Background: Doxorubicin is a highly effective anti-cancer drug that causes left ventricular (LV) dysfunction and induces late-onset cardiomyopathy. However, an effective and clinically applicable preventive treatment is yet to be...
3.
Kang D, Kim Y, Min S, Lee S, Chung K, Baek I, et al.
Cell Rep
. 2023 Nov;
42(11):113361.
PMID: 37910508
Vascular endothelial growth factor receptor-2 (VEGFR2) plays a key role in maintaining vascular endothelial homeostasis. Here, we show that blood flows determine activation and inactivation of VEGFR2 through selective cysteine...
4.
Cho E, Kim M, Kim Y, Chang K, Choi D, Kang W, et al.
J Clin Hypertens (Greenwich)
. 2023 Aug;
25(9):817-827.
PMID: 37614053
The authors evaluated the efficacy, safety, and characteristics of patients who respond well to standard dose triple combination therapy including chlorthalidone 25 mg with telmisartan 80 mg plus amlodipine 5 ...
5.
Sung K, Hong S, Rhee M, Jeong M, Kim D, Lim S, et al.
J Clin Hypertens (Greenwich)
. 2023 Apr;
25(5):429-439.
PMID: 37095689
We compared the efficacy and safety of third-standard-dose triple and third-standard-dose dual antihypertensive combination therapies in patients with mild to moderate hypertension. This was a phase II multicenter, randomized, double-blind,...
6.
Kim J, Kwon K, Kim K, Han S, Kim P, Choi J
Nanomaterials (Basel)
. 2023 Jan;
13(1).
PMID: 36616000
Li metal has been intensively investigated as a next-generation rechargeable battery anode. However, its practical application as the anode material is hindered by the deposition of dendritic Li. To suppress...
7.
Jeon E, Lim S, Kim S, Yang H, Kim M, Rhee M, et al.
Clin Hypertens
. 2022 Dec;
28(1):40.
PMID: 36451242
Background: To assess the efficacy and safety of a combination therapy involving fimasartan, amlodipine, and rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond to fimasartan monotherapy....
8.
Kook H, Yu C, Choi D, Ahn T, Chang K, Cho J, et al.
Clin Ther
. 2022 Apr;
44(4):508-528.
PMID: 35410753
Purpose: Renexin® is a combination pill of cilostazol and Ginkgo biloba leaf extract that is used for the improvement of ischemic symptoms associated with peripheral arterial disease (PAD). SID142 is...
9.
Chung J, Kim K, Yu N, An S, Lee S, Kwon K
Int J Mol Sci
. 2022 Feb;
23(3).
PMID: 35163238
Blood fluid shear stress (FSS) modulates endothelial function and vascular pathophysiology. The small extracellular vesicles (sEVs) such as exosomes are potent mediators of intercellular communication, and their contents reflect cellular...
10.
Kang I, Kwon K
BMB Rep
. 2021 Dec;
55(1):30-38.
PMID: 34903320
Cardiovascular disease, especially ischemic heart disease, is a major cause of mortality worldwide. Cardiac repair is one of the most promising strategies to address advanced cardiovascular diseases. Despite moderate improvement...